These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2817798)
21. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors. Milas L; Hersh EM; Stringfellow DA; Hunter N J Natl Cancer Inst; 1982 Jan; 68(1):139-45. PubMed ID: 6172625 [TBL] [Abstract][Full Text] [Related]
22. Reduction of B16 melanoma metastases by oral administration of egg-white lysozyme. Sava G Cancer Chemother Pharmacol; 1989; 25(3):221-2. PubMed ID: 2598413 [TBL] [Abstract][Full Text] [Related]
23. [Experimental studies on antitumor effects of lysozyme]. Fukawa K; Nishimura N; Irino O; Nakazato K; Taguchi A; Nitta K Gan To Kagaku Ryoho; 1982 May; 9(5):915-23. PubMed ID: 7184434 [TBL] [Abstract][Full Text] [Related]
24. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse. Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054 [TBL] [Abstract][Full Text] [Related]
25. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers. Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786 [TBL] [Abstract][Full Text] [Related]
26. Allogeneic cell therapy for a murine mammary carcinoma. Morecki S; Yacovlev E; Diab A; Slavin S Cancer Res; 1998 Sep; 58(17):3891-5. PubMed ID: 9731499 [TBL] [Abstract][Full Text] [Related]
27. Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity. Bergamo A; Gava B; Alessio E; Mestroni G; Serli B; Cocchietto M; Zorzet S; Sava G Int J Oncol; 2002 Dec; 21(6):1331-8. PubMed ID: 12429985 [TBL] [Abstract][Full Text] [Related]
28. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma. Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446 [TBL] [Abstract][Full Text] [Related]
29. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism. Shibata MA; Ito Y; Morimoto J; Otsuki Y Carcinogenesis; 2004 Oct; 25(10):1887-98. PubMed ID: 15180944 [TBL] [Abstract][Full Text] [Related]
30. Cytofluorimetric analysis of gut-intraepithelial and mesenteric lymph node lymphocytes of tumour bearing mice fed with egg-white lysozyme. Pacor S; Giacomello E; Bergamo A; Gagliardi R; Cocchietto M; Sava G Anticancer Res; 1996; 16(1):145-9. PubMed ID: 8615600 [TBL] [Abstract][Full Text] [Related]
31. [Inhibitory effect of UFT on postoperative lung metastasis of mammary adenocarcinoma in SHR rats]. Komatsumoto M; Li S; Hamada J; Takeichi N; Hosokawa M; Okayasu T; Tanabe T; Kobayashi H Gan To Kagaku Ryoho; 1988 May; 15(5):1739-45. PubMed ID: 3130810 [TBL] [Abstract][Full Text] [Related]
32. Vaticanol C, a novel resveratrol tetramer, reduces lymph node and lung metastases of mouse mammary carcinoma carrying p53 mutation. Shibata MA; Akao Y; Shibata E; Nozawa Y; Ito T; Mishima S; Morimoto J; Otsuki Y Cancer Chemother Pharmacol; 2007 Oct; 60(5):681-91. PubMed ID: 17256131 [TBL] [Abstract][Full Text] [Related]
33. Lysozyme and cancer: role of exogenous lysozyme as anticancer agent (review). Sava G; Benetti A; Ceschia V; Pacor S Anticancer Res; 1989; 9(3):583-91. PubMed ID: 2669620 [TBL] [Abstract][Full Text] [Related]
34. Isolation of a murine metastatic cell line and preliminary test of sensitivity to the anti-metastasis agent NAMI-A. Pacor S; Vadori M; Vita F; Bacac M; Soranzo MR; Zabucchi G; Sava G Anticancer Res; 2001; 21(4A):2523-30. PubMed ID: 11724317 [TBL] [Abstract][Full Text] [Related]
35. [Experimental studies on antitumor effects of lysozyme-II. Effect of lysozyme on immunopotentiation]. Fukawa K; Nishimura N; Irino O; Nitta K Gan To Kagaku Ryoho; 1982 Oct; 9(10):1832-7. PubMed ID: 7184377 [TBL] [Abstract][Full Text] [Related]
36. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors. Wietrzyk J; Opolski A; Madej J; Radzikowski C Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263 [TBL] [Abstract][Full Text] [Related]
37. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice. Gorelik E Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083 [TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes. Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488 [TBL] [Abstract][Full Text] [Related]
39. Effects of concomitant and sinecomitant immunity on postsurgical metastasis in mice. Nomi S; Naito K; Kahan BD; Pellis NR Cancer Res; 1986 Dec; 46(12 Pt 1):6111-5. PubMed ID: 3779631 [TBL] [Abstract][Full Text] [Related]
40. Potentiation of antitumor immunity in tumor-bearing mice by a degraded D-manno-D-glucan (DMG), a new antitumor polysaccharide. Nakajima H; Kita Y; Hashimoto S; Tsukada W; Abe S; Mizuno D Jpn J Exp Med; 1983 Dec; 53(6):281-8. PubMed ID: 6680757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]